Form 4 for BSX Boston Scientific
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-24 · accession 0001225208-25-002386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-25 | 2025-02-24+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $104.16 | -7,363 | 25.8K | -22% | -$766.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | S | D | 4,675 | $104.25 | 28,454 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-25 | S | D | 2,688 | $104.00 | 25,766 | D | — | — |